Latest Breaking News On - மாற்றி அமைக்கத்தக்க உயிரி தொழில்நுட்பங்கள் - Page 5 : comparemela.com
How Seattle Seeded A Life Sciences Boom
bisnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bisnow.com Daily Mail and Mail on Sunday newspapers.
New accelerator in Seattle: Creative Destruction Lab to launch deep tech startup hub with Microsoft, UW
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.
Adaptive Biotechnologies: Q1 Earnings Snapshot
May 5, 2021 GMT
SEATTLE (AP) Adaptive Biotechnologies Corp. (ADPT) on Wednesday reported a loss of $40.6 million in its first quarter.
On a per-share basis, the Seattle-based company said it had a loss of 29 cents.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 41 cents per share.
The life-sciences research company posted revenue of $38.4 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $28.5 million.
Adaptive Biotechnologies shares have decreased 40% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $35.46, a rise of slightly more than 7% in the last 12 months.
• Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.
• EyePoint Pharmaceuticals (NASDAQ:EYPT) is likely to report quarterly loss at $0.46 per share on revenue of $7.93 million.
• Fortis (NYSE:FTS) is projected to report quarterly earnings at $0.75 per share on revenue of $2.50 billion.
• Madison Square Garden (NYSE:MSGS) is expected to report quarterly loss at $1.80 per share on revenue of $148.62 million.
• America First Multifamily (NASDAQ:ATAX) is projected to report quarterly earnings at $0.12 per share on revenue of $19.09 million.
• Ardmore Shipping (NYSE:ASC) is estimated to report quarterly loss at $0.31 per share on revenue of $24.86 million.
(ADPT) - Earnings Outlook for Adaptive Biotechnologies
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.